Valuation: Hikma Pharmaceuticals PLC

Capitalization 355.59Cr 306.59Cr 276.76Cr 265.56Cr 484.24Cr 33TCr 506.78Cr 3.27TCr 1.31TCr 16TCr 1.33TCr 1.31TCr 56TCr P/E ratio 2025
11.5x
P/E ratio 2026 * 8.51x
Enterprise value 455.62Cr 392.84Cr 354.62Cr 340.26Cr 620.47Cr 42TCr 649.35Cr 4.19TCr 1.68TCr 20TCr 1.71TCr 1.67TCr 72TCr EV / Sales 2025
1.38x
EV / Sales 2026 * 1.35x
Free-Float
65.88%
Yield 2025 *
5.02%
Yield 2026 * 5%
1 day-0.08%
1 week-7.99%
Current month-7.99%
1 month-21.49%
3 months-24.15%
6 months-29.71%
Current year-22.00%
1 week 1,205
Extreme 1205
1,290
1 month 1,205
Extreme 1205
1,667
Current year 1,205
Extreme 1205
1,691
1 year 1,205
Extreme 1205
2,172
3 years 1,205
Extreme 1205
2,360
5 years 1,174.5
Extreme 1174.5
2,703
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Director of Finance/CFO 54 01/01/2001
Compliance Officer - 01/01/2024
Investor Relations Contact - 01/11/2005
Director TitleAgeSince
Director/Board Member 68 14/10/2005
Director/Board Member 54 15/12/2025
Chairman 68 15/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
-0.08%-7.99%-44.13%-31.98% 355.59Cr
+0.72%-5.86%+8.50%+210.49% 88TCr
+0.32%-3.23%+44.97%+54.54% 58TCr
-0.96%-0.85%+9.19%+48.19% 41TCr
-2.93%-7.03%+12.72%+26.04% 35TCr
-1.25%-5.55%+23.92%+55.59% 30TCr
-1.85%-6.70%+20.55%+34.98% 30TCr
-0.24%-6.49%+23.18%+4.22% 29TCr
+0.53%-4.80%+16.27%+57.17% 20TCr
-0.83%-3.37%+24.03%+77.45% 18TCr
Average -0.66%-5.02%+13.92%+53.67% 34.92TCr
Weighted average by Cap. -0.47%-4.60%+19.81%+85.96%

Financials

2025 2026 *
Net sales 332.7Cr 286.85Cr 258.94Cr 248.46Cr 453.07Cr 31TCr 474.16Cr 3.06TCr 1.23TCr 15TCr 1.25TCr 1.22TCr 52TCr 348.76Cr 300.7Cr 271.44Cr 260.45Cr 474.94Cr 32TCr 497.05Cr 3.21TCr 1.29TCr 15TCr 1.31TCr 1.28TCr 55TCr
Net income 44Cr 38Cr 34Cr 33Cr 60Cr 4.06TCr 63Cr 406.54Cr 162.87Cr 1.95TCr 165.83Cr 162.29Cr 6.96TCr 41Cr 36Cr 32Cr 31Cr 56Cr 3.79TCr 59Cr 379.26Cr 151.94Cr 1.82TCr 154.7Cr 151.4Cr 6.5TCr
Net Debt 100.04Cr 86Cr 78Cr 75Cr 136.23Cr 9.19TCr 142.57Cr 920.42Cr 368.74Cr 4.41TCr 375.44Cr 367.44Cr 16TCr 115.68Cr 100Cr 90Cr 86Cr 157.54Cr 11TCr 164.87Cr 1.06TCr 426.42Cr 5.1TCr 434.17Cr 424.92Cr 18TCr
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC specializes in developing, producing, and selling drugs used in treating cardiovascular diseases, infections, cancers, diabetes, etc. Net sales break down by family of products as follows: - generic injectable products (41.8%); - generic products taken orally (32.8%); - brand name drugs (24.68%); - other (0.8%). Net sales are distributed geographically as follows: the United Kingdom (0.4%), the United States (61.1%), Middle East and North Africa (31.5%) and other (7%).
Employees
9,400
Date Price Change Volume
06/26/06 1,209.00 p -0.08% 14,32,350
05/26/05 1,210.00 p -3.12% 13,79,686
04/26/04 1,249.00 p +0.16% 15,63,652
03/26/03 1,247.00 p -0.16% 19,60,338
02/26/02 1,249.00 p -4.95% 17,91,615
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
16.19USD
Average target price
27.36USD
Spread / Average Target
+69.03%

Quarterly revenue - Rate of surprise